| Field | Specification |
|---|---|
| Target | |
| Alternative names | 72 kDa type IV collagenase;3.4.24.24;72 kDa gelatinase;Gelatinase A;Matrix metalloproteinase-2;MMP-2;TBE-1;PEX;MMP2;CLG4A; |
| UniProt # | |
| Host | |
| Clone | |
| Clonality | |
| Isotype | |
| Reactivity | |
| Applications | |
| Immunogen | A synthesized peptide derived from human MMP2 |
| Molecular weight | |
| Purification | |
| Reconstitution | |
| Cellular localization | |
| Concentration | |
| Form | Liquid |
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
Clone BBA-13 is a rabbit monoclonal antibody that recognizes 72 kDa type IV collagenase (gene MMP2) in human, mouse and rat samples and is validated for Western blot and IHC. The predicted molecular weight is 73.9 kDa, and the supplier reports an observed band at about 95 kDa.
MMP-2 (gelatinase A, 72 kDa type IV collagenase) is a widely expressed matrix metalloproteinase that degrades type IV collagen of basement membranes, gelatin and other matrix proteins. It is involved in vascular remodeling, angiogenesis and tissue repair, and gelatin zymography of MMP-2 is a common readout in studies of cell invasion, cardiovascular disease and cancer.
| Target | 72 kDa type IV collagenase (gene MMP2; UniProt P08253, human) |
|---|---|
| Clone | BBA-13 |
| Host / Clonality / Isotype | Rabbit / Monoclonal / Rabbit IgG |
| Reactivity | Human, Mouse, Rat |
| Form | Liquid |
| Formulation | PBS (pH 7.4); 150 mM NaCl; 0.02% sodium azide; 50% glycerol; plus stabilizers |
| Calculated MW | 73.9 kDa |
| Observed MW | 95 kDa |
| Storage | Long term: −20 °C for up to 12 months. Frequent use: 4 °C for up to 1 month. Avoid repeated freeze–thaw cycles. |
Validated Applications
| Western blot | 1:500–1:2000 |
|---|---|
| Immunohistochemistry | 1:50–1:200 |
Samples with a confirmed band (WB): human HepG2 cells.
Recommended loading (WB): 20–40 µg of total protein per lane.
Conditions in the example images (WB): 5–20% gradient SDS-PAGE under reducing conditions, 30 µg lysate per lane, transfer to nitrocellulose membrane, blocking in 5% non-fat milk, primary antibody at 1:500 overnight at 4 °C, HRP-conjugated secondary antibody at 1:5000, ECL detection.
Samples with confirmed staining (IHC): human breast cancer tissue.
Recommended antigen retrieval: heat-mediated, in TE buffer (pH 9.0); citrate buffer (pH 6.0) can be used instead.
Conditions in the example images (IHC): heat-mediated antigen retrieval in EDTA buffer (pH 8.0).
Immunogen
Synthetic peptide based on the sequence of human MMP2.
Reactivity Notes
The supplier lists reactivity with human, mouse and rat. Tissue expression noted by UniProt (human): Produced by normal skin fibroblasts. The samples tested by the supplier (listed above) are a practical starting point for positive controls.
Safety
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
Yan Liu et al. (2024) Oral Piwi-Interacting RNA Delivery Mediated by Green Tea-Derived Exosome-Like Nanovesicles for the Treatment of Aortic Dissection. Advanced Healthcare Materials. 10.1002/adhm.202401466
Chen Jia et al. (2020) Decoy receptor 2 mediation of the senescent phenotype of tubular cells by interacting with peroxiredoxin 1 presents a novel mechanism of renal fibrosis in diabetic nephropathy. Kidney International. 10.1016/j.kint.2020.03.026
Jia-ning Gong et al. (2026) Platycodin D alleviates idiopathic pulmonary fibrosis by targeting PPP2R1A and regulating the PP2A-mediated PI3K/Akt pathway to inhibit fibroblast transdifferentiation. Phytomedicine. 10.1016/j.phymed.2026.158000
Zheng Zeng et al. (2023) Enterolactone and trabectedin suppress epithelial ovarian cancer synergistically via upregulating THBS1. Phytotherapy Research. 10.1002/ptr.7942
Shaoru Zhang et al. (2022) Chronic exposure to microcystin-leucine-arginine induces epithelial hyperplasia and inflammation in the mouse bladder. Ecotoxicology and Environmental Safety. 10.1016/j.ecoenv.2022.114033
Hanwei Ma et al. (2022) Licoricidin combats gastric cancer by targeting the ICMT/Ras pathway in vitro and in vivo. Frontiers in Pharmacology. 10.3389/fphar.2022.972825
Nan Li et al. (2025) An inhalable composite particulate system for targeted delivery of therapeutics deep into small airways: in vitro and in vivo evaluation. International Journal of Pharmaceutics. 10.1016/j.ijpharm.2025.126053
Qingsong Zhang et al. (2017) Enhancing E-cadherin expression via promoter-targeted miR-373 suppresses bladder cancer cells growth and metastasis. Oncotarget. 10.18632/oncotarget.21400
Xu Jing et al. (2007) HAb18G/CD147 Functions in Invasion and Metastasis of Hepatocellular Carcinoma. Molecular Cancer Research. 10.1158/1541-7786.MCR-06-0286
Huijuan Li et al. (2026) Resveratrol suppresses GATA4/Sortilin pathway to attenuate vascular smooth muscle cell senescence-associated secretory phenotype and vascular aging-related atherosclerosis. Cellular Signalling. 10.1016/j.cellsig.2026.112669
